Bataclan, M.* ; Leoni, C.* ; Moro, S.G.* ; Pecoraro, M.* ; Wong, E.H.* ; Heissmeyer, V. ; Monticelli, S.*
Crosstalk between Regnase-1 and -3 shapes mast cell survival and cytokine expression.
Life Sci. All. 7:e202402784 (2024)
Post-transcriptional regulation of immune-related transcripts by RNA-binding proteins (RBPs) impacts immune cell responses, including mast cell functionality. Despite their importance in immune regulation, the functional role of most RBPs remains to be understood. By manipulating the expression of specific RBPs in murine mast cells, coupled with mass spectrometry and transcriptomic analyses, we found that the Regnase family of proteins acts as a potent regulator of mast cell physiology. Specifically, Regnase-1 is required to maintain basic cell proliferation and survival, whereas both Regnase-1 and -3 cooperatively regulate the expression of inflammatory transcripts upon activation, with Tnf being a primary target in both human and mouse cells. Furthermore, Regnase-3 directly interacts with Regnase-1 in mast cells and is necessary to restrain Regnase-1 expression through the destabilization of its transcript. Overall, our study identifies protein interactors of endogenously expressed Regnase factors, characterizes the regulatory interplay between Regnase family members in mast cells, and establishes their role in the control of mast cell homeostasis and inflammatory responses.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Rna-binding Proteins; Au-rich Elements; Messenger-rna; Immune-responses; Tnf-alpha; T-cells; Roquin; Degradation; Database; Cleavage
Keywords plus
Language
english
Publication Year
2024
Prepublished in Year
0
HGF-reported in Year
2024
ISSN (print) / ISBN
2575-1077
e-ISSN
2575-1077
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 7,
Issue: 8,
Pages: ,
Article Number: e202402784
Supplement: ,
Series
Publisher
EMBO Press
Publishing Place
Heidelberg
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-501712-001
Grants
Aldo and Cele Dacco Foundation
Swiss National Science Foundation
Copyright
Erfassungsdatum
2024-07-19